Pacira BioSciences (PCRX) Change in Cash (2010 - 2026)

Pacira BioSciences' Change in Cash history runs 17 years deep, the most recent figure standing at -$14.2 million for Q1 2026.

• In Q1 2026, Change in Cash fell 308.29% year-over-year to -$14.2 million; the TTM figure through Mar 2026 stood at -$139.3 million (down 239.92% YoY), while the FY2025 annual figure was -$118.2 million, down 195.75% from the prior year.
• Change in Cash for Q1 2026 stood at -$14.2 million, down from $11.0 million in the prior quarter.
• The five-year high for Change in Cash was $63.0 million in Q2 2024, with the low at -$358.8 million in Q1 2022.
• The 5-year median for Change in Cash is $6.8 million (2025), against an average of -$26.0 million.
• The sharpest annual moves came in 2023 and 2025: Change in Cash soared 1125.15% in 2023, then sank 13952.85% in 2025.
• Pacira BioSciences' Change in Cash stood at -$5.3 million in 2022, then jumped by 1125.15% to $54.2 million in 2023, then tumbled by 43.13% to $30.8 million in 2024, then plunged by 64.44% to $11.0 million in 2025, then tumbled by 229.97% to -$14.2 million in 2026.
• Business Quant data shows PCRX's Change in Cash at -$14.2 million in Q1 2026, $11.0 million in Q4 2025, and -$152.9 million in Q3 2025.